J J Kim

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance
    Jane J Kim
    Department of Health Policy and Management, Harvard Center for Risk Analysis, 718 Huntington Ave, Second Floor, Boston, MA 02115, USA
    JAMA 287:2382-90. 2002
  2. pmc Mathematical model of HPV provides insight into impacts of risk factors and vaccine
    Jane J Kim
    Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 3:e164. 2006
  3. ncbi Multiparameter calibration of a natural history model of cervical cancer
    Jane J Kim
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Am J Epidemiol 166:137-50. 2007
  4. pmc Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
    Jane J Kim
    Harvard School of Public Health, Department of Health Policy and Management, Center for Health Decision Science, 718 Huntington Avenue, Boston, MA 02115, USA
    BMJ 339:b3884. 2009
  5. pmc Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
    E A Burger
    Department of Health Management and Health Economics, University of Oslo, Norway
    Br J Cancer 106:1571-8. 2012
  6. doi Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA)
    Jane J Kim
    Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA Electronic address
    Vaccine 31:G65-77. 2013
  7. doi Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa
    Jane J Kim
    Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA Electronic address
    Vaccine 31:F60-72. 2013
  8. pmc Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
    BMC Med 11:23. 2013
  9. pmc Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency, London, UK
    BMC Med 9:54. 2011
  10. pmc The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting
    J J Kim
    Department of Health Policy and Management, Harvard School of Public Health, Program in Health Decision Science, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, USA
    Br J Cancer 97:1322-8. 2007

Detail Information

Publications32

  1. ncbi Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance
    Jane J Kim
    Department of Health Policy and Management, Harvard Center for Risk Analysis, 718 Huntington Ave, Second Floor, Boston, MA 02115, USA
    JAMA 287:2382-90. 2002
    ..Every year approximately 2 million US women are diagnosed as having a cervical cytological result of atypical squamous cells of undetermined significance (ASC-US)...
  2. pmc Mathematical model of HPV provides insight into impacts of risk factors and vaccine
    Jane J Kim
    Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 3:e164. 2006
  3. ncbi Multiparameter calibration of a natural history model of cervical cancer
    Jane J Kim
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Am J Epidemiol 166:137-50. 2007
    ..The authors found that leveraging primary data from longitudinal studies provides unique opportunities for model parameterization of the unobservable nature of HPV infection and its role in the development of cervical cancer...
  4. pmc Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
    Jane J Kim
    Harvard School of Public Health, Department of Health Policy and Management, Center for Health Decision Science, 718 Huntington Avenue, Boston, MA 02115, USA
    BMJ 339:b3884. 2009
    ..To assess the cost effectiveness of including preadolescent boys in a routine human papillomavirus (HPV) vaccination programme for preadolescent girls...
  5. pmc Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway
    E A Burger
    Department of Health Management and Health Economics, University of Oslo, Norway
    Br J Cancer 106:1571-8. 2012
    ..We evaluated the cost-effectiveness of alternative screening strategies to inform cervical cancer prevention guidelines in Norway...
  6. doi Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA)
    Jane J Kim
    Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA Electronic address
    Vaccine 31:G65-77. 2013
    ..Updates of the progress in the field are presented in a separate monograph entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012. ..
  7. doi Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa
    Jane J Kim
    Center for Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA Electronic address
    Vaccine 31:F60-72. 2013
    ..Updates of the progress in the field are presented in a separate monograph entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012. ..
  8. pmc Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
    BMC Med 11:23. 2013
    ..This report describes the consensus of an expert group convened by the World Health Organization, prioritizing key issues to be addressed when considering economic analyses to support HPV vaccine introduction in these countries...
  9. pmc Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
    Mark Jit
    Modelling and Economics Unit, Health Protection Agency, London, UK
    BMC Med 9:54. 2011
    ..To provide information about the feasibility of using such models in a developing country setting, we evaluated models of HPV vaccination in terms of their capacity, requirements, limitations and comparability...
  10. pmc The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting
    J J Kim
    Department of Health Policy and Management, Harvard School of Public Health, Program in Health Decision Science, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, USA
    Br J Cancer 97:1322-8. 2007
    ..In a resource-constrained setting such as Brazil, our results support that the first priority in reducing cervical cancer mortality should be to vaccinate pre-adolescent girls...
  11. pmc Health and economic implications of HPV vaccination in the United States
    Jane J Kim
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    N Engl J Med 359:821-32. 2008
    ..The cost-effectiveness of prophylactic vaccination against human papillomavirus types 16 (HPV-16) and 18 (HPV-18) is an important consideration for guidelines for immunization in the United States...
  12. pmc Modeling cervical cancer prevention in developed countries
    Jane J Kim
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    Vaccine 26:K76-86. 2008
    ..The objective of this review is to highlight points of consensus and qualitative themes, to discuss the areas of divergent findings, and to provide insight into critical decisions related to cervical cancer prevention...
  13. pmc Packaging health services when resources are limited: the example of a cervical cancer screening visit
    Jane J Kim
    Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 3:e434. 2006
    ....
  14. doi Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis
    Jane J Kim
    Harvard School of Public Health, Department of Health Policy and Management, Center for Health Decision Science, Boston, MA, USA
    Lancet Infect Dis 10:845-52. 2010
    ..High-risk populations such as men who have sex with men (MSM) might especially benefit from vaccination. I aimed to estimate the cost-effectiveness of HPV vaccination of MSM in the USA...
  15. doi Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy
    Jane J Kim
    Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
    Vaccine 26:4015-24. 2008
    ..e., <$5 per dose), and screening is offered at older ages...
  16. pmc Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in women older than 30 years in the United States
    Jane J Kim
    Department of Health Policy and Management, Center for Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
    Ann Intern Med 151:538-45. 2009
    ..The role of vaccination against HPV types 16 and 18, which is recommended routinely for preadolescent girls, is unclear in this age group...
  17. ncbi Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy
    Jane J Kim
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    J Natl Cancer Inst 97:888-95. 2005
    ..We assessed the cost-effectiveness of incorporating HPV DNA testing into existing cervical cancer screening programs in the United Kingdom, The Netherlands, France, and Italy...
  18. doi Cost-effectiveness of psychotherapy for cluster C personality disorders: a decision-analytic model in the Netherlands
    Djøra I Soeteman
    Viersprong Institute for Studies on Personality Disorders VISPD, PO Box 7, 4660 AA Halsteren, The Netherlands
    J Clin Psychiatry 72:51-9. 2011
    ..To conduct a formal economic evaluation of various dosages of psychotherapy for patients with avoidant, dependent, and obsessive-compulsive (ie, cluster C) personality disorders (Structured Interview for DSM-IV Personality criteria)...
  19. ncbi Chapter 19: Cost-effectiveness of cervical cancer screening
    Sue J Goldie
    Department of Health Policy and Management, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
    Vaccine 24:S3/164-70. 2006
    ..Despite differences in methods and assumptions, this paper identifies the qualitative themes that are consistent among studies, and highlights important methodological challenges and high-priority areas for further work...
  20. doi Mathematical models of cervical cancer prevention in the Asia Pacific region
    Sue J Goldie
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    Vaccine 26:M17-29. 2008
    ....
  21. ncbi Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more
    Sue J Goldie
    Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115 5924, USA
    Obstet Gynecol 103:619-31. 2004
    ..To evaluate the cost-effectiveness of human papillomavirus (HPV) DNA testing as a primary screening test in combination with cervical cytology in women aged 30 years or more...
  22. ncbi Cost-effectiveness of HPV 16, 18 vaccination in Brazil
    Sue J Goldie
    Department of Health Policy and Management, Program in Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, 2nd Floor, Boston, MA 02115, United States of America
    Vaccine 25:6257-70. 2007
    ....
  23. pmc Persistence of concurrent infections with multiple human papillomavirus types: a population-based cohort study
    Nicole G Campos
    Center for Health Decision Science, Harvard School of Public Health, Boston, Massachusetts, USA
    J Infect Dis 203:823-7. 2011
    ..9; log-rank test). Concurrent, prevalent detection of additional HPV types did not change the likelihood of viral persistence...
  24. doi Cost-effective psychotherapy for personality disorders in the Netherlands: the value of further research and active implementation
    Djøra I Soeteman
    Viersprong Institute for Studies on Personality Disorders VISPD, Halsteren, The Netherlands
    Value Health 14:229-39. 2011
    ..The objective of this study was to assess the societal value of conducting further research to inform reimbursement decisions and implementation of cost-effective psychotherapy for clusters B and C personality disorders (PDs)...
  25. doi Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand
    M Sharma
    Department of Health Policy and Management, Center for Health Decision Science, Harvard School of Public Health, Boston, MA 02115, USA
    BJOG 119:166-76. 2012
    ..To assess the health and economic outcomes of various screening and vaccination strategies for cervical cancer prevention...
  26. ncbi Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong
    Jane J Kim
    Harvard Center for Risk Analysis, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    J Public Health (Oxf) 26:130-7. 2004
    ..To assess the cost-effectiveness of alternative cervical cancer screening strategies to inform the design and implementation of a government-sponsored population-based screening programme in Hong Kong...
  27. ncbi Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS)
    Shalini L Kulasingam
    Department of Obstetrics and Gynecology, Duke University, Durham, NC, USA
    J Natl Cancer Inst 98:92-100. 2006
    ..We conducted a cost-effectiveness analysis of the ALTS trial to determine whether HPV DNA testing is a cost-effective alternative to immediate colposcopy or conservative management with up to three cytology examinations...
  28. ncbi Vaccine policy analyses can benefit from natural history studies of human papillomavirus in men
    Jane J Kim
    J Infect Dis 196:1117-9. 2007
  29. ncbi Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes
    Geoffrey P Garnett
    Department of Infectious Disease Epidemiology, Imperial College London, St Mary s Campus, Norfolk Place, London, UK
    Vaccine 24:S3/178-86. 2006
    ..To date, model results are consistent in predicting a useful role for vaccine, but further epidemiological data are required to help test the validity of models...
  30. ncbi What is the most cost-effective population-based cancer screening program for Chinese women?
    Pauline P S Woo
    Department of Community Medicine and School of Public Health, University of Hong Kong, Pokfulam, Hong Kong, China
    J Clin Oncol 25:617-24. 2007
    ..To develop a policy-relevant generalized cost-effectiveness (CE) model of population-based cancer screening for Chinese women...
  31. ncbi Cost-effectiveness analysis of treatment strategies for Stage I and II endometrial cancer
    Janice S Kwon
    Department of Obstetrics and Gynecology, University of Western Ontario, London
    J Obstet Gynaecol Can 29:131-9. 2007
    ..We evaluated the cost-effectiveness of two common strategies for managing early endometrial cancer as part of an Ontario population-based study...
  32. doi Human papillomavirus vaccination in the UK
    Jane J Kim
    BMJ 337:a842. 2008